Platform Technology Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $549K | Sell |
1,234
-31
| -2% | -$13.8K | 0.14% | 143 |
|
|
2025
Q1 | $613K | Hold |
1,265
| – | – | 0.18% | 117 |
|
|
2024
Q4 | $510K | Sell |
1,265
-1
| -0.1% | -$403 | 0.15% | 117 |
|
|
2024
Q3 | $588K | Sell |
1,266
-90
| -7% | -$41.8K | 0.19% | 109 |
|
|
2024
Q2 | $636K | Buy |
+1,356
| New | +$636K | 0.22% | 100 |
|
|
2023
Q4 | $576K | Sell |
1,377
-50
| -4% | -$20.9K | 0.22% | 104 |
|
|
2023
Q3 | $496K | Hold |
1,427
| – | – | 0.23% | 99 |
|
|
2023
Q2 | $488K | Sell |
1,427
-21
| -1% | -$7.18K | 0.23% | 102 |
|
|
2023
Q1 | $456K | Sell |
1,448
-130
| -8% | -$41K | 0.23% | 107 |
|
|
2022
Q4 | $456K | Hold |
1,578
| – | – | 0.24% | 105 |
|
|
2022
Q3 | $457K | Sell |
1,578
-47
| -3% | -$13.6K | 0.26% | 99 |
|
|
2022
Q2 | $458K | Sell |
1,625
-27
| -2% | -$7.61K | 0.25% | 103 |
|
|
2022
Q1 | $431K | Sell |
1,652
-30
| -2% | -$7.83K | 0.21% | 117 |
|
|
2021
Q4 | $369K | Sell |
1,682
-89
| -5% | -$19.5K | 0.16% | 142 |
|
|
2021
Q3 | $321K | Buy |
1,771
+13
| +0.7% | +$2.36K | 0.15% | 160 |
|
|
2021
Q2 | $354K | Buy |
+1,758
| New | +$354K | 0.15% | 164 |
|
|
2020
Q4 | $418K | Buy |
1,769
+331
| +23% | +$78.2K | 0.2% | 125 |
|
|
2020
Q3 | $391K | Buy |
1,438
+18
| +1% | +$4.89K | 0.24% | 110 |
|
|
2020
Q2 | $412K | Buy |
1,420
+5
| +0.4% | +$1.45K | 0.29% | 96 |
|
|
2020
Q1 | $337K | Buy |
1,415
+200
| +16% | +$47.6K | 0.31% | 99 |
|
|
2019
Q4 | $266K | Buy |
+1,215
| New | +$266K | 0.2% | 132 |
|